The Case for Public Funding and Public Oversight of Clinical Trials

Faculty Co-Director Jerome Reichman and Senior Fellow Dr. Anthony So argue in The Economists’ Voice that clinical drug trials are public goods and should be publicly funded to avoid undersupply, suppression of adverse results, and other problems (with Tracy Lewis)